|
Pharma companies today face increasing regulatory pressure and must meet ambitious sustainability goals. At the same time, they are often held back by aging infrastructure. Electrification is therefore no longer just an energy decision – it has become a strategic lever.
Modular electrification, innovative financing models, and digitalization help pharma companies strengthen their resilience, comply with GMP regulations, and ensure that sustainability goals are met.
This executive research report shows how leading companies are using electrification as the foundation for compliance, operational resilience, and digital transformation.
|
